Search
for
Sort by
Research 211–240 of 953
- How to distinguish medicalization from over-medicalization?
- Evaluation of the effects of COVID‐19 pandemic on hair diseases through a web‐based questionnaire
- Nonsurgical Management of Facial Masculinization and Feminization
- How to Speak Postmodern: Medicine, Illness, and Cultural Change
- One of These Things Is Not Like the Others: The Idea of Precedence in Health Technology Assessment and Coverage Decisions
- Profile of dermatological consultations in Brazil (2018)
- Gender-Affirming Hormone Therapy for Transgender Females
- Experimental and Clinical Pharmacology of<i>Ziziphus jujuba</i>Mills
- Polycystic ovary syndrome: A review for dermatologists
- Gender-Affirming Hormone Therapy for Transgender Men
- Thymosin β4 Promotes Dermal Healing
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- The Black identity, hair product use, and breast cancer scale
- Male hormonal contraception: looking back and moving forward
- Tourniquet syndrome: Interest of a systematic analysis of families’ social conditions to detect neglect situations
- Contraception and the dermatologist
- What Specialties Perform the Most Common Outpatient Cosmetic Procedures in the United States?
- The Essence of Alternative Medicine
- Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study
- Considerations in genetic counseling of transgender patients: Cultural competencies and altered disease risk profiles
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- Comparison of patients’ diagnoses in a dermatology outpatient clinic during the COVID‐19 pandemic period and pre‐pandemic period
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Developing a Framework for Sources of New Product Ideas
- Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome?
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
- Capitalising on ageing anxieties: Promissory discourse and the creation of an ‘anti-ageing treatment’ market
- Skin health of community-living older people: a scoping review
- A Critical Review on Obstetric Follow-up of Women Affected by Systemic Lupus Erythematosus
- The Endoscopic Brow Lift